Standard visual field testing — the machine where you press a button when you see a flash of light — is designed for the peripheral visual field. It maps the entire field from center to far periphery, which is what you need for glaucoma. But for diseases of the central retina (macula), it’s imprecise. The macula covers only 5 degrees of visual angle but provides nearly all detail and color vision. Testing it with a standard perimeter is like trying to map a single room by flying over a city.
Microperimetry solves this by projecting test stimuli directly onto a fundus image — the examiner can see exactly which retinal location received each stimulus and measure the sensitivity at that precise anatomic point. It’s the most accurate way to quantify central visual function in macular disease, and it’s increasingly standard for monitoring AMD, Stargardt disease, macular hole, and macular dystrophies.
Who Needs Microperimetry
Microperimetry is most valuable when:
- Age-related macular degeneration (AMD): Tracking functional sensitivity changes over time or in response to anti-VEGF treatment; identifying scotomas (blind spots) in the central field
- Stargardt disease and other macular dystrophies: Documenting functional status and rate of progression
- Macular hole pre- and post-surgery: Assessing central visual function before vitrectomy and verifying improvement afterward
- Epiretinal membrane: Quantifying central distortion and scotoma depth
- Retinal gene therapy trials: Microperimetry is a required endpoint in most gene therapy clinical trials for retinal dystrophies — it’s the functional measurement that regulators and sponsors use to prove a treatment works
The National Eye Institute funded several landmark studies on AMD progression using microperimetry endpoints, underscoring its clinical importance for this disease category.
Cost Overview
| Setting | Low | Typical | High |
|---|---|---|---|
| Academic medical center / retina specialist | $150 | $275 | $500 |
| Private retina practice | $175 | $300 | $450 |
| Low vision rehabilitation center | $100 | $200 | $350 |
| Research setting (clinical trial) | $0 | $0 | $0 (covered by study) |
| Annual monitoring (2 sessions/year) | $300 | $550 | $1,000 |
What the Test Involves
Microperimetry takes 15–25 minutes per eye. You’re seated at the device (the MAIA, Nidek MP-3, and CenterVue RADIANCE are the main instruments in US practices), your head is stabilized with a chin and forehead rest, and you look at a fixation target while small light stimuli are presented at various locations across the central 10–20 degrees of your field.
The key difference from standard perimetry: the instrument continuously tracks where you’re looking via infrared retinal imaging and projects each stimulus at its planned anatomic location regardless of small fixation movements. This means the test results are tied to specific retinal anatomy — you can see, on a fundus photo overlay, exactly which retinal cells responded normally and which showed reduced sensitivity.
Pupil dilation is typically not required for microperimetry, though some protocols prefer dilated conditions for better fundus image quality.
Coverage is inconsistent and depends heavily on the diagnosis and the insurer. Medicare covers visual field testing (CPT 92083) and covers microperimetry when billed under the same code with appropriate documentation of medical necessity. However, many commercial insurers classify microperimetry as “experimental” or “investigational” for specific indications and may deny coverage. The devices used (MAIA, MP-3) are FDA-cleared, and billing under 92083 with an ICD-10 code for AMD (H35.31xx), Stargardt (H35.51xx), or macular hole (H35.23x) gives the best chance of coverage. Prior authorization is sometimes required; your retina specialist’s billing staff can navigate this. Out-of-pocket costs when insurance denies: $150–$500 per session.
How Microperimetry Differs from Standard Visual Field Testing
| Feature | Standard Perimetry (Humphrey) | Microperimetry |
|---|---|---|
| Field coverage | 24–2° or 30–2° central field | 10–20° macular zone |
| Retinal registration | None (stimulus location is assumed) | Real-time fundus tracking |
| Fixation stability measurement | Indirect | Direct quantification |
| Primarily used for | Glaucoma, neuro-ophthalmic disease | Macular disease, retinal dystrophy |
| Sensitivity resolution | Moderate | High (maps individual retinal loci) |
For glaucoma monitoring, standard perimetry remains the gold standard. For macular disease — especially when you need to know whether anti-VEGF injections are preserving or improving central sensitivity — microperimetry provides data that standard perimetry simply can’t.
Fixation Stability: A Unique Microperimetry Output
Microperimetry provides something standard perimetry doesn’t: quantitative fixation stability mapping. The instrument plots where the patient’s fixation point falls during the test and classifies it as:
- Stable fixation: 75%+ of fixation points within a 2° circle — normal
- Relatively unstable: Intermediate scatter
- Unstable: Scattered fixation, usually indicating a central scotoma that forces use of an eccentric preferred retinal locus (PRL)
This fixation data is critical for AMD rehabilitation. Patients who have developed a PRL — a non-central point they use as their “new center” because the fovea is damaged — can be identified, and vision rehabilitation specialists can train them to use their PRL more effectively. The NEI funded research showing that structured PRL training with microperimetry biofeedback significantly improves reading speed and quality of life in patients with geographic atrophy from AMD.
Finding Microperimetry in Practice
Not every eye clinic has a microperimeter — the MAIA (the most widely used instrument in the US, made by CenterVue/iCare) costs approximately $60,000–$80,000, which limits availability to retina practices, academic centers, and specialized low vision programs.
To find microperimetry:
- Ask your retina specialist whether their practice has a MAIA, Nidek MP-3, or similar device
- Academic ophthalmology departments with dedicated retina divisions typically have it
- Low vision rehabilitation centers affiliated with university programs often have microperimetry capability
Don’t confuse microperimetry with the Amsler grid, which is a home screening tool for distortion. The Amsler grid is useful for catching new scotomas or metamorphopsia that might signal progression, but it can’t quantify sensitivity, register results to retinal anatomy, or measure fixation stability. Microperimetry provides objective, quantitative data that’s appropriate for tracking disease progression and guiding treatment decisions. If your retina doctor recommends it, it’s because the clinical question they’re trying to answer can’t be answered with an Amsler grid alone.